Adverse outcomes and mortality in users of non-steroidal anti-inflammatory drugs who tested positive for SARS-CoV-2: A Danish nationwide cohort study-Reference-Cited by-同舟云学术

Adverse outcomes and mortality in users of non-steroidal anti-inflammatory drugs who tested positive for SARS-CoV-2: A Danish nationwide cohort study

Published:2020-09-08 Issue:9 Volume:17 Page:e1003308
ISSN:1549-1676
Container-title:PLOS Medicine
language:en
Short-container-title:PLoS Med

Author:

Lund Lars Christian^ORCID,Kristensen Kasper Bruun^ORCID,Reilev Mette^ORCID,Christensen Steffen,Thomsen Reimar Wernich^ORCID,Christiansen Christian Fynbo^ORCID,Støvring Henrik^ORCID,Johansen Nanna Borup^ORCID,Brun Nikolai Constantin,Hallas Jesper^ORCID,Pottegård Anton^ORCID

Publisher

Public Library of Science (PLoS)

Subject

General Medicine

Reference34 articles.

1. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?;L Fang;Lancet Respir Med.,2020

2. Covid-19: ibuprofen should not be used for managing symptoms, say doctors and scientists;M Day;BMJ,2020

3. European Medicines Agency. EMA gives advice on the use of non-steroidal anti-inflammatories for COVID-19. EMA/136850/2020. Amsterdam: European Medicines Agency; 2020 [cited 2020 Aug 3]. Available from: https://www.ema.europa.eu/en/news/ema-gives-advice-use-non-steroidal-anti-inflammatories-covid-19.

4. Nonsteroidal antiinflammatory drug use and clinical outcomes of community-acquired pneumonia;D Basille;Am J Respir Crit Care Med,2018

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of Aspirin Use on the Adverse Outcomes in Patients Hospitalized for COVID-19;Cardiology Research;2024-06

2. NSAIDs for early management of acute respiratory infections;Current Opinion in Infectious Diseases;2024-05-23

3. Evaluating NSAIDs in SARS-CoV-2: Immunomodulatory mechanisms and future therapeutic strategies;Heliyon;2024-02

4. NSAID prescribing and adverse outcomes in common infections: a population-based cohort study;BMJ Open;2024-01

5. Ibuprofen, other NSAIDs and COVID-19: a narrative review;Inflammopharmacology;2023-08-21